Clovis Oncology Inc

NASDAQ:CLVS   1:08:36 PM EDT
0.68
+0.01 (+1.58%)
Earnings Announcements

Clovis Oncology Announces First Quarter 2022 Operating Results And Provides Update On Clinical Development Programs

Published: 05/04/2022 13:47 GMT
Clovis Oncology Inc (CLVS) - Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs.
Q1 Loss per Share $0.44.
Qtrly Global Net Product Revenues of $34.2 Million Versus $38.1 Million.
Q1 Earnings per Share View $-0.43, Revenue View $37.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $38.83 Million
Adjusted EPS is expected to be -$0.41

Next Quarter Revenue Guidance is expected to be $42.37 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.